Glibornuride is an oral, second-generation sulfonylurea medication used to treat type 2 diabetes mellitus. It lowers blood glucose levels by stimulating the pancreas to release insulin. It is generally prescribed for patients who still retain some residual pancreatic beta-cell function. It is grouped under the following drug class(es): Hypoglycemics and Sulfonylureas. Its therapeutic use is listed as antidiabetic agents. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Glutril and Glibornuridum. Its PubChem CID is 12818200.
Glibornuride
| CAS No | 26944-48-9 |
|---|---|
| Molecular Formula | C18H26N2O4S |
| Molecular Weight | 366.5 g/mol |
| Synonyms | 1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Glibornuride is an oral, second-generation sulfonylurea medication used to treat type 2 diabetes mellitus. It lowers blood glucose levels by stimulating the pancreas to release insulin.
The listed CAS number is 26944-48-9.
The listed molecular formula is C18H26N2O4S.
The listed molecular weight is 366.5 g/mol.
1-[(1S,2S,3R,4R)-3-hydroxy-4,7,7-trimethyl-2-bicyclo[2.2.1]heptanyl]-3-(4-methylphenyl)sulfonylurea.
The source lists Glutril and Glibornuridum.